New Delhi: SC to hear PIL on Chikunguniya menace in the state

Published On 2016-09-23 10:05 GMT   |   Update On 2016-09-23 10:05 GMT

New Delhi: The Supreme Court has decided to hear a public interest litigation (PIL) asking the Delhi government to take adequate measures to control the spread of vector-borne diseases- chikungunya, dengue and malaria- in the city.The apex court division bench, headed by Justice Anil R. Dave, will hear the plea on September 26.The PIL, filed by a Delhi-based doctor, Anil Mittal, raises...

Login or Register to read the full article

New Delhi: The Supreme Court has decided to hear a public interest litigation (PIL) asking the Delhi government to take adequate measures to control the spread of vector-borne diseases- chikungunya, dengue and malaria- in the city.


The apex court division bench, headed by Justice Anil R. Dave, will hear the plea on September 26.


The PIL, filed by a Delhi-based doctor, Anil Mittal, raises the issue of the national capital being used a dumping ground and implicates the South Delhi Municipal Corporation and other wards as parties in the case.


The Delhi Health Minister, Satyendra Jain had apprised the state Chief Minister Arvind Kejriwal about a Delhi High court order that  had asked the Municipal Corporation of Delhi (MCD)  to take preventive measures to help control the spread of these diseases last year.



Kejriwal has charged the MCD for not carrying out fogging properly and has asked the state health minister to see to take adequate measures in the matter, said Jain to ANI.

Meanwhile, Delhi Deputy Chief Minister Manish Sisodia held a press conference announcing that he will ensure dengue, chikungunya and malaria are kept under check through intensive fogging throughout the city.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News